Literature DB >> 8641752

Evidence that a region(s) of the Clostridium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or large complexes.

J F Kokai-Kun1, B A McClane.   

Abstract

In studies performed to investigate the topology of Clostridium perfringens enterotoxin (CPE) when this toxin is associated with intestinal brush border membrane (BBMs), it was shown that radiolabeled CPE antibodies react more strongly against intact CPE-treated BBMs than against control BBMs. Immunoprecipitation studies then demonstrated that CPE antibodies are able to react with both small and large CPE-containing complexes while these complexes are still present in intact BBMs. Therefore, at least a portion of the CPE molecule appears to remain surface exposed in BBMs throughout the action of this toxin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641752      PMCID: PMC173873          DOI: 10.1128/iai.64.3.1020-1025.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  A hydrophobic form of the small-intestinal sucrase-isomaltase complex.

Authors:  H Sigrist; P Ronner; G Semenza
Journal:  Biochim Biophys Acta       Date:  1975-10-17

2.  Binding versus biological activity of Clostridium perfringens enterotoxin in Vero cells.

Authors:  J L McDonel; B A McClane
Journal:  Biochem Biophys Res Commun       Date:  1979-03-30       Impact factor: 3.575

3.  Primary action of Clostridium perfringens type A enterotoxin on HeLa and Vero cells in the absence of extracellular calcium: rapid and characteristic changes in membrane permeability.

Authors:  M Matsuda; K Ozutsumi; H Iwahashi; N Sugimoto
Journal:  Biochem Biophys Res Commun       Date:  1986-12-15       Impact factor: 3.575

4.  Use of a monoclonal antibody to determine the mode of transmembrane pore formation by streptolysin O.

Authors:  F Hugo; J Reichwein; M Arvand; S Krämer; S Bhakdi
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

5.  Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin.

Authors:  A P Wnek; R J Strouse; B A McClane
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

6.  Early events in the action of staphylococcal alpha-toxin on the plasma membrane of adrenocortical Y1 tumor cells.

Authors:  L Blomqvist; M Thelestam
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

Review 7.  Clostridium perfringens enterotoxin acts by producing small molecule permeability alterations in plasma membranes.

Authors:  B A McClane
Journal:  Toxicology       Date:  1994-02-28       Impact factor: 4.221

8.  Binding of Clostridium perfringens [125I]enterotoxin to rabbit intestinal cells.

Authors:  J L McDonel
Journal:  Biochemistry       Date:  1980-10-14       Impact factor: 3.162

9.  Protective effects of osmotic stabilizers on morphological and permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin.

Authors:  B A McClane; J L McDonel
Journal:  Biochim Biophys Acta       Date:  1981-03-06

10.  Osmotic stabilizers differentially inhibit permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin.

Authors:  B A McClane
Journal:  Biochim Biophys Acta       Date:  1984-10-17
View more
  6 in total

1.  Deletion analysis of the Clostridium perfringens enterotoxin.

Authors:  J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Crystallization and preliminary crystallographic analysis of the Clostridium perfringens enterotoxin.

Authors:  David C Briggs; James G Smedley; Bruce A McClane; Ajit K Basak
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-06-24

3.  Identification and characterization of sporulation-dependent promoters upstream of the enterotoxin gene (cpe) of Clostridium perfringens.

Authors:  Y Zhao; S B Melville
Journal:  J Bacteriol       Date:  1998-01       Impact factor: 3.490

4.  Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment.

Authors:  E U Wieckowski; J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 5.  Clostridium perfringens enterotoxin (CPE) and CPE-binding domain (c-CPE) for the detection and treatment of gynecologic cancers.

Authors:  Jonathan D Black; Salvatore Lopez; Emiliano Cocco; Carlton L Schwab; Diana P English; Alessandro D Santin
Journal:  Toxins (Basel)       Date:  2015-04-01       Impact factor: 4.546

Review 6.  Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.

Authors:  Diana P English; Alessandro D Santin
Journal:  Int J Mol Sci       Date:  2013-05-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.